Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alibaba Health Information Technology ( (HK:0241) ) has shared an update.
Alibaba Health Information Technology Limited has established a Nomination Committee to ensure effective governance and diversity within its board of directors. The committee will be composed mainly of independent non-executive directors and will focus on maintaining a diverse and skilled board to align with the company’s corporate strategy. This move is expected to enhance the company’s governance structure and support its strategic objectives by ensuring a balanced representation of skills and backgrounds on the board.
The most recent analyst rating on (HK:0241) stock is a Buy with a HK$4.20 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the health technology industry, focusing on providing digital health services and solutions. The company is incorporated in Bermuda and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 122,151,721
Technical Sentiment Signal: Buy
Current Market Cap: HK$81.88B
See more insights into 0241 stock on TipRanks’ Stock Analysis page.